최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.30 no.3, 2020년, pp.143 - 148
Objective: This study aimed to investigate pharmaceutical care for critically ill neonates and suggest targeted strategies compatible with the Korean health-system pharmacy. Methods: Articles that reported pharmacy practices for critically ill neonates were reviewed. Pharmaceutical care practices an...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
신생아중환자실 입원 환자를 위해 약사가 어떤 역할을 하는가? | 신생아중환자실 입원 환자를 위한 약물사용의 전 과정에서 약사는 다양한 방식으로 역할을 하고 있다(Table 1). 약물 처방 단계에서는 의사에게 의약품 정보를 제공하고, 약물 처방 검토와 중재 업무를 수행한다.6,14,16,19) 회진에 참여하고, 약물요법과 영양지원에 대한 자문을 통해 약물치료결정에 도움을 주고 있다.22) 국내에서는 2005년도에 소아 전담 임상약사들이 주도하여 신생아를 포함한 소아의 약용량 데이터베이스를 구축하고, 처방용량의 오류가 발생하였을 때 알림창을 제시하는 소아약물처방스크린 프로그램을 개발하였다. | |
신생아중환자에 대한 약료서비스의 형태는 각 나라마다 어떠한 것으로 보고되는가? | 22,27,42) 또한 약사가 약제부서 내에서 근무하며 의약품의 조제 및 관리를 담당하고, 전화나 전자커뮤니케이션을 통하여 약료서비스를 제공하는 형태로 수행되고 있다.22,42) 호주와 폴란드의 신생아중환자 약료서비스 현황 비교 연구에서 호주는 93%의 약사가 신생아중환자실 내에서 약료서비스를 제공하고 있으나, 폴란드는 96%의 약사가 조제실에서 근무하며 약료서비스를 제공한다고 보고했다.42)미국, 영국, 호주 등의 국가에서는 신생아중환자실에 상주하는 담당약사에 의한 환자중심의 임상약료서비스가 활발하게 수행되고 있으며, 약력 검토, 회진 참여, TDM, 의약정보제공 등이 주요 업무로 보고되고 있다.22) 국내에서도 신생아중환자실에 임상약사가 상주하며 약료서비스를 제공하는 병원들이 있으며,26-27) 영양전문약사가 집중영양치료팀의 구성원으로 참여하면서 약료서비스를 제공하는 형태가 있으나,24) 국내 신생아중환자 약료서비스의 형태에 대하여 보고하고 있는 문헌이 많지 않아 전반적인 현황 파악을 위한 추가 연구가 필요할 것으로 사료된다. | |
신생아중환자실에 입원한 환자들의 나이대는 어떠한 것으로 나타나는가? | 22) 국내에서는 2005년도에 소아 전담 임상약사들이 주도하여 신생아를 포함한 소아의 약용량 데이터베이스를 구축하고, 처방용량의 오류가 발생하였을 때 알림창을 제시하는 소아약물처방스크린 프로그램을 개발하였다.32) 신생아중환자실에 입원한 환자들은 재태연령(gestational age)이 24주에서 41주, 체중이 0.5 kg에서 4 kg 정도로 신체기관의 다양한 성숙 정도를 나타내고 있으므로 이에 따른 세분화된 약물용량 지침이 제시되고 있다. |
Ohlinger J, Brown MS, Laudert S, Swanson S, Fofah O; CARE Group. Development of potentially better practices for the neonatal intensive care unit as a culture of collaboration: communication, accountability, respect, and empowerment. Pediatrics 2003;111:e471-81.
Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285(16):2114-20.
Dabliz R, Levine S. Medication safety in neonates. Am J Perinatol 2012;29(1):49-56.
Jain S, Basu S, Parmar VR. Medication errors in neonates admitted in intensive care unit and emergency department. Indian J Med Sci 2009;63(4):145-51.
Chappell K, Newman C. Potential tenfold drug overdoses on a neonatal unit. Arch Dis Child Fetal Neonatal Ed 2004;89(6):F483-4.
Chedoe I, Molendijk HA, Dittrich ST, et al. Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety: a review of the current literature. Drug Saf 2007;30(6):503-13.
Gray JE, Goldmann DA. Medication errors in the neonatal intensive care unit: special patients, unique issues. Arch Dis Child Fetal Neonatal Ed 2004;89(6):F472-3.
Campino A, Lopez-Herrera MC, Lopez-de-Heredia I, Valls-i-Soler A. Educational strategy to reduce medication errors in a neonatal intensive care unit. Acta Paediatr 2009;98(5):782-5.
Cordero L, Kuehn L, Kumar RR, Mekhjian HS. Impact of computerized physician order entry on clinical practice in a newborn intensive care unit. J Perinatol 2004;24(2):88-93.
Johnson FL, Winship HW, Trinca CE. Neonatal medication surveillance by the pharmacist. Am J Hosp Pharm 1977;34(6):609-12.
Johnson CJ, Lobas NH, Ivey MF. Development of a pharmaceutical care system in a neonatal intensive care satellite pharmacy. Am J Hosp Pharm 1993;50(6):1158-63.
Dice JE, Burckart GJ, Woo JT, Helms RA. Standardized versus pharmacist-monitored individualized parenteral nutrition in lowbirth-weight infants. Am J Hosp Pharm 1981;38(10):1487-9.
Bryant BG. Clinical pharmacist emerging member of the NICU team. Neonatal Netw 1985;3(6):40-4.
Lobas NH, Armitstead JA, Ivey MF. Expanding staff pharmacists' responsibilities to maintain pharmacy services in a neonatal intensive-care unit. Am J Hosp Pharm 1991;48(8):1708-11.
Mills B, Fensterheim L, Taitel M, Cannon A. Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital. Vaccine 2014;32(4):521-5.
Simpson JH, Lynch R, Grant J, Alroomi L. Reducing medication errors in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed 2004;89(6):F480-2.
Schellack N, Gous AGS. An overview of the time needed to render critical ward services in a neonatal intensive care unit: documenting the activities of a clinical pharmacist: original research. S Afr Pharm J 2011;78(7):1-3.
Mulholland PJ. Pharmacists as non-medical prescribers: what role can they play? The experience in a neonatal intensive care unit. Eur J Hosp Pharm 2014;21:335-8.
de Jager Z, Schellack N, Gous A. What role does the clinical pharmacist play in the neonatal intensive care unit? S Afr Pharm J 2014;81(7):22-3.
Ragab MH, Al-Hindi MY, Alrayees MM. Neonatal parenteral nutrition: Review of the pharmacist role as a prescriber. Saudi Pharm J 2016;24(4):429-40.
Dunkley MK. Neonatal intensive care - an Australian survey of the pharmacist's role. Aust J Hosp Pharm 1991;21:104-8.
Krzyzaniak N, Bajorek B. A global perspective of the roles of the pharmacist in the NICU. Int J Pharm Pract 2017:25(2):107-20.
Kim SL, Lee JY, Ro SY, et al. Growth curves and factors associated with growth of premature infants during initial hospitalization. J Kor Soc Health-Syst Pharm 2002;19(3):243-8.
An SH, Kim JY, Gwak HS. Outcomes of a new dosage regimen of amikacin based on pharmacokinetic parameters of Korean neonates. Am J Health Syst Pharm 2014;71(2):122-7.
Park TY, Kim YH, Jung YM, Lee JW, Lee ES. The comparison analysis of the prevention of adverse drug events through order interventions by designated-pharmacists. J Kor Soc Health-Syst Pharm 2014;31(1):638-43.
Jung JW, Kang YJ, Moon MY, et al. Preliminary study for economic evaluation of clinical pharmacist intervention. J Kor Soc Health-Syst Pharm 2011;28(4):327-36.
Kim YH, Rho JH, Suh YW, et al. Pharmacist interventions in neonatal intensive care unit associated cost avoidance and cost savings. J Kor Soc Health-syst Pharm 2018;35(3):281-91.
Oh YK, Lee GS, Rhie S. Neonatal total nutritional pharmacy service at intensive care unit at a university hospital in Korea. Korean J Clin Pharm 2013;23(2):167-74.
Doh HJ, Yoon IK, Choi KS, et al. Evaluation of empiric vancomycin dosing regimens among neonates in a Korean tertiary care hospital. J Kor Soc Health-syst Pharm 2016;33(2):130-40.
Choi DW, Ye KN, Kim JT, An SH. Phenobarbital dosing and therapeutic drug monitoring in the neonatal intensive care unit. Yakhak Hoeji 2018;62(1):49-53.
Kim SL, Kim JY, An SH, Kang MK, Shin HY. Impact of clinical decision support system and clinical pharmacist in pediatrics. J Kor Soc Health-Syst Pharm 2006;23(2):95-103.
Taketomo CK, Hodding JH, Kraus DM. Pediatric & Neonatal Dosage Handbook, 19th ed. Hudson, OH: Lexi-Comp, 2012; 787-90, 1715-19.
An SH, Kim JY, Song YC. Prevention of medication errors by clinical pharmacist and the computerized decision support system (CDSS) in neonatal intensive care unit. Pharmacotherapy 2009;29(3):128e
Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005;164(9):522-8.
Bae HJ, Shin YJ, Shin HJ, et al. Off-label drug use in neonatal intensive care unit: a tertiary center experience. J Kor Soc Healthsyst Pharm 2019;36(3):325-34.
Al-Turkait A, Szatkowski L, Choonara I, Ojha S. Review of drug utilization studies in neonatal units: a global perspective. Int J Environ Res Public Health 2020;17(16):E5669
Krzyzaniak N, Pawlowska I, Bajorek B. Review of drug utilization patterns in NICUs worldwide. J Clin Pharm Ther 2016;41(6):612-20.
Johnson MR, Nash DR, Laird MR, Kiley RC, Martinez MA. Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol. J Pediatr Pharmacol Ther 2014;19(3):165-73.
Willis ZI, Gillon J, Xu M, Slaughter JC, Di Pentima MC. Reducing antimicrobial use in an academic pediatric institution: Evaluation of the effectiveness of a prospective audit with real-time feedback. J Pediatric Infect Dis Soc 2017;6(4):339-345
Hamdy RF, Bhattarai S, Basu SK, et al. Vancomycin use in a level IV NICU. Pediatrics 2020;146(2):e20192963.
Krzyzaniak N, Pawlowska I, Bajorek B. The role of the clinical pharmacist in the NICU: a cross-sectional survey of Australian and Polish pharmacy practice. Eur J Hosp Pharm 2018;25(e1):e7-e16.
Leopoldino RD, Santos MT, Costa TX, Martins RR, Oliveira AG. Drug related problems in the neonatal intensive care unit: incidence, characterization and clinical relevance. BMC Pediatr 2019;19(1):134.
Nascimento ARFD, Leopoldino RWD, Santos METD, Costa TXD, Martins RR. Drug-related problems in cardiac neonates under intensive care. Rev Paul Pediatr 2020;38:e2018134.
Loureiro CV, Fonteles MM, Mascarenhas MB, Chaves EF, Firmino PY. Medication follow-up in newborns with extremely low birthweight. Pharm Pract (Granada) 2019;17:1584.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.